Supernus Pharmaceuticals
SUPN
#4472
Rank
A$2.76 B
Marketcap
$49.59
Share price
0.55%
Change (1 day)
-5.18%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total debt

Total debt on the balance sheet as of December 2024 : A$54.22 Million

According to Supernus Pharmaceuticals 's latest financial reports the company's total debt is A$54.22 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Supernus Pharmaceuticals - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2024-12-31A$55.09 M-9.61%
2023-12-31A$60.95 M-90.67%
2022-12-31A$0.65 B10.96%
2021-12-31A$0.58 B9.31%
2020-12-31A$0.53 B-0.31%
2019-12-31A$0.54 B15.58%
2018-12-31A$0.46 B
2017-12-31N/A-100%
2016-12-31A$5.77 M-40.59%
2015-12-31A$9.72 M-69.65%
2014-12-31A$32.04 M-16.9%
2013-12-31A$38.55 M75%
2012-12-31A$22.03 M-23.38%
2011-12-31A$28.75 M-61.05%
2010-12-31A$73.83 M-11.56%
2009-12-31A$83.49 M-21.46%
2008-12-31A$0.10 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.47 B 775.38%๐Ÿ‡บ๐Ÿ‡ธ USA
A$53.23 B 98,071.05%๐Ÿ‡บ๐Ÿ‡ธ USA
A$81.00 B 149,297.45%๐Ÿ‡บ๐Ÿ‡ธ USA
A$23.76 B 43,730.06%๐Ÿ‡บ๐Ÿ‡ธ USA
A$57.96 B 106,795.04%๐Ÿ‡บ๐Ÿ‡ธ USA